FDA Warns Supplement Maker CC Pollen

FDA Warning Letter Hits Bee Supplement Maker CC Pollen — Quality checks are the core of the supplement rules the FDA says were violated at the Arizona plant, per the agency's January 9, 2026 letter.

The FDA sent a warning letter to CC Pollen Company of Glendale, Arizona, on January 9, 2026, stating that the company's Bee Pollen Granules and Royal Jelly capsules were adulterated because they were manufactured under conditions that violate the federal quality rules for dietary supplements, per the FDA, 2026.

This site publishes information, not medical or legal advice, and nothing here accuses the company of anything beyond what the agency's own letter states; the company can respond and correct the cited conditions. If you take bee-derived supplements and have symptoms that concern you, talk with a clinician.

What did the FDA actually allege?

The letter, posted on the FDA's warning-letters database, cites failures under the supplement quality system known as CGMP (21 CFR Part 111), per the FDA, 2026. Inspectors who visited the plant in April 2025 found, according to the letter: no finished-product specifications for identity, purity, strength, and composition; quality-control staff who did not approve or reject component specifications; and no written master manufacturing record for a unique formulation.

The letter also describes one detail that stands out in quality-control terms: a component lot that failed a spectroscopic identity match — scoring 80.37 against a criterion of greater than 85 — was still used in manufacturing, per the FDA, 2026. On labeling, the agency said the Royal Jelly capsules list a serving of one capsule while the directions say one to two capsules daily, a mismatch it called misbranding.

What happens next for the company?

A warning letter is not a lawsuit, a recall, or a finding of guilt. It asks CC Pollen to document corrective action within 15 working days and notes that the agency may pursue seizure or injunction if the violations are not corrected, per the FDA, 2026. Many warning-letter recipients respond with a written plan, retest ingredients, or update labels; the FDA posts those exchanges in its public database.

What this changes for readers

For shoppers, the practical takeaway is about manufacturing discipline, not bee pollen itself. The FDA does not test supplements for quality before they are sold, so a company's own quality system is the main safeguard — which is why CGMP enforcement letters matter as a signal. You can check any brand's name in the FDA's public warning-letters database before you buy, and you can report a reaction through the agency's MedWatch system, per the FDA, 2026.

The bottom line

Per the FDA, 2026, CC Pollen Company has 15 working days to respond to allegations of serious quality-system gaps at its Arizona plant. The letter is an enforcement demand, not a final legal outcome. If you use royal jelly or bee pollen supplements, the next sensible step is checking the FDA database and, if you have any concerning symptoms, talking to your clinician.

Frequently Asked Questions

Does an FDA warning letter mean the products are dangerous?

Not by itself. A warning letter documents alleged regulatory violations and demands corrective action; it is not a recall, seizure, or court finding. The FDA notes it may pursue further action, such as seizure or injunction, if the violations are not corrected, per the agency's January 9, 2026 letter.

What are CGMP rules for supplements?

Current Good Manufacturing Practice rules (21 CFR Part 111) require supplement makers to verify ingredient identity, set specifications for purity and strength, keep master manufacturing records, and test finished products. The FDA does not pre-approve supplements, so these quality rules are the main legal safeguard.

Can I still buy royal jelly or bee pollen supplements?

The letter did not order products off shelves. Whether you buy is your call; the sensible step is checking the FDA's warning-letters database for the company and asking a clinician or pharmacist if you take medications or have allergies, especially to bee products.

How do I report a bad reaction to a supplement?

You can report to the FDA through its MedWatch program, per the FDA. Also tell your clinician, since supplement reactions can interact with medications and are often underreported.

Sources

posted on the FDA's warning-letters database